
ARYZTA (SWX:ARYN) just confirmed that interim Chief Executive Officer and current Chairman Urs Jordi will become permanent CEO after the 2027 annual general meeting, reinforcing the existing leadership approach.
ARYZTA’s share price has climbed over the past month, with a 30 day share price return of 9.96% and a 7 day gain of 6.24%. However, the 1 year total shareholder return is down 24.28% and the 3 year total shareholder return has declined 35.65%. This suggests that recent momentum is improving against a weaker long term record as investors reassess the business at roughly 10.3x earnings and respond to continuity in leadership around Urs Jordi’s appointment.
Spot potential rebound candidates beyond ARYZTA by scanning our curated 189 high quality undervalued stocks with similar earnings multiples and recent share price pressure.ARYZTA’s recent bounce has only scratched the surface of a share price that is still down sharply over three years. Is this where most of the recovery sits ahead, or already in the rear-view mirror?
ARYZTA’s most followed narrative points to a fair value of CHF57.82 against the last close of CHF40.85, so the gap between price and modelled worth is still wide, even after the recent rebound.
Persistent execution of structural cost savings, digitalization (ERP rollout, business service center expansion), and procurement initiatives are set to deliver incremental efficiency gains and margin expansion, directly improving profitability and supporting long-term earnings growth.
See why 11 investors see ARYZTA as 29% undervalued.
The fair value estimate of CHF57.82 is built using a 3.95% discount rate and assumes ARYZTA can hold margins near 5.6% while growing revenue at a little over 2% a year. That keeps the narrative anchored in relatively modest expansion rather than aggressive forecasts. To line up with the analyst target, the shares would need to trade on a P/E of about 13x those future earnings, which is lower than the 19.7x currently used for the GB Food industry in the same framework.
Analysts inside this narrative are not fully aligned. The most optimistic view points to CHF75.05 per share while the most cautious sits near CHF39.97, which already brackets the current price. That spread reflects real uncertainty around how much pricing power ARYZTA can hold if input costs stay volatile and consumers keep trading down. It also means readers may want to treat the 29.4% discount to fair value as a central case rather than a precise target.
Underlying all of this is a business that produced €2.2b of revenue and €105.0m of net income, with about 89% of sales coming from Europe and the balance from the Rest of World segment. The model assumes revenue can edge up to roughly €2.3b and earnings to €132.0m by 2029, supported by new capacity, product refreshes and cost work. If those inputs prove too optimistic, the implied fair value could shift lower despite the current discount signal.
Result: Fair Value of CHF57.82 (UNDERVALUED)
Still, the ARYZTA narrative hinges on two pressure points: sustained cost inflation in key ingredients and a softer consumer backdrop that could curb pricing power just when it matters most.
Find out about the key risks to this ARYZTA narrative.
Mixed signals so far, right, with ARYZTA showing both pressure points and bright spots in the latest narrative. Act quickly by weighing both sides in the 3 key rewards and 1 important warning sign.
Do not stop your research with one stock. Broaden your watchlist with a few focused idea lists that match different risk levels and income goals.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com